188123-56-0

Basic information

• Product Name: 5-(3-(3-methoxyl-p-hydroxyphenyl)-1-oxo-2-propenyl)-2,2'-bithiophene
• Synonyms: 5-(3-(3-methoxyl-p-hydroxyphenyl)-1-oxo-2-propenyl)-2,2'-bithiophene
• CAS NO: 188123-56-0
• Molecular Weight: 342.439
• Mol File: 188123-56-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 5-(3-(3-methoxyl-p-hydroxyphenyl)-1-oxo-2-propenyl)-2,2'-bithiophene(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(3-(3-methoxyl-p-hydroxyphenyl)-1-oxo-2-propenyl)-2,2'-bithiophene(188123-56-0)
• EPA Substance Registry System: 5-(3-(3-methoxyl-p-hydroxyphenyl)-1-oxo-2-propenyl)-2,2'-bithiophene(188123-56-0)

Safety Data

• Hazardous Substances Data: 188123-56-0(Hazardous Substances Data)

Upstream product

• 110-87-2 3,4-dihydro-2H-pyran 
• 3515-18-2 5-acetyl-2,2'-bithiophene 
• 104-15-4 toluene-4-sulfonic acid 
• 121-33-5 vanillin 

Relevant articles and documents

Medicinal thiophene compounds

A method of treating tumor including administering to a subject an effective amount of a compound of the following formula: STR1 wherein m is 1-4; and each of A and B, independently, is H, C1-7 alkyl, C2-7 alkenyl, C2-7 alkynyl, (CH2)n CHO, (CH2)o COOH, C1-7 alkoxy, C2-7 alkoxyalkyl, C1-7 hydroxyalkyl, CN, NO2, halogen, CH(OR1)2, CO.R1, NR2 R3 or its acid salt, CO.NR2 R3, CHR1 NR2 R3 or its acid salt, CH=NR2, C CR4, CR1 =CR5 R6, CO.CH=CHR7, CH=CHR8, or COOR9 ; in which each of n and o, independently, is 0-4; R1 is C1-4 alkyl or C1-4 acyl; each of R2 and R3, independently, is H, C1-4 alkyl, or C1-4 hydroxyalkyl; R4 is H, C1-4 alkyl, C2-4 alkenyl, COR2, COOR10, C1-4 hydroxyalkyl or its acid ester or 2-tetrahydropyranyl ether, C1-4 dihydroxyalkyl or its acid ester or 2-tetrahydropyranyl ether, C1-4 halogenated alkyl; OR1, or NHR7 ; each of R5 and R6, independently, is H, CHO, COR1, COOH, COOR9, CN, or halogen; R7 is H, C1-4 alkyl, 2-thienyl, phenyl, mono-substituted phenyl, or di-substituted phenyl; R8 is COOR2, CO.CHO, C1-4 hydroxyalkyl or its acid ester or 2-tetrahydropyranyl ether; and R9 is H, C1-4 alkyl, phenyl, mono-substituted phenyl, di-substituted phenyl, or 2-thienyl.

Medicinal thiophene compounds

A method of treating inflammation including administering to a subject an effective amount of a compound of the following formula: STR1 wherein m is 1-4; and each of A and B, independently, is H, C1-7 alkyl, C2-7 alkenyl, C2-7 alkynyl, (CH2)n CHO, (CH2)o COOH, C1-7 alkoxy, C2-7 alkoxyalkyl, C1-7 hydroxyalkyl, CN, NO2, halogen, CH(OR1)2, CO.R1, NR2 R3 or its acid salt, CO.NR2 R3, CHR1 NR2 R3 or its acid salt, CH=NR2, C CR4, CR1 =CR5 R6, CO.CH=CHR7, CH=CHR8, or COOR9 ; in which each of n and o, independently, is 0-4; R1 is C1-4 alkyl or C1-4 acyl; each of R2 and R3, independently is H, C1-4 alkyl, or C1-4 hydroxyalkyl; R4 is H, C1-4 alkyl, C2-4 alkenyl, COR2, COOR10, C1-4 hydroxyalkyl or its acid ester or 2-tetrahydropyranyl ether, C1-4 dihydroxyalkyl or its acid ester or 2-tetrahydropyranyl ether, C1-4 halogenated alkyl; OR1, NHR7 ; each of R5 R6, independently, is H, CHO, COR1, COOH, COOR9, CN, or halogen; R7 is H, C1-4 alkyl, 2-thienyl, phenyl, mono-substituted phenyl, or di-substituted phenyl; R8 is COOR2, CO.CHO, C1-4 hydroxyalkyl or its acid ester or 2-tetrahydropyranyl ether; and R9 is H, C1-4 alkyl, phenyl, mono-substituted phenyl, di-substituted phenyl, or 2 -thienyl.